Supriya Lifescience boosts API capacity with Rs 125cr Module E facility

Pallavi Madhiraju- December 17, 2024 0

Supriya Lifescience Ltd, a leading player in the pharmaceutical industry growth segment, has unveiled its latest Module E production block at its cutting-edge facility in ... Read More

Supriya Lifescience, Plasma Nutrition to partner on ioProtein manufacturing in India

Pallavi Madhiraju- August 2, 2023 0

Mumbai-based company Supriya Lifescience Ltd, specializing in active pharmaceutical ingredients (API), has announced a groundbreaking collaboration with United States-based Plasma Nutrition, Inc. This exclusive technology ... Read More

Ami Organics wins multi-million Euro supply contract from Fermion

Pallavi Madhiraju- November 27, 2022 0

Ami Organics has signed a multi-year, multi-tonne agreement with Fermion, a wholly-owned subsidiary of Finland-based Orion Corporation for the supply of an intermediate for its ... Read More

PI Industries scraps Rs 15.3bn acquisition of lnd Swift’s API unit

pallavi123- November 2, 2021 0

PI Industries Ltd (PIIND), an Indian agri-sciences company, said that its previously announced INR 1,530 crores acquisition of the active pharmaceutical ingredient (API) business division ... Read More

PI Industries to acquire API business of lnd Swift Laboratories

pallavi123- July 31, 2021 0

PI Industries Ltd, an Indian agri-sciences company, has agreed to acquire the API business division of lnd Swift Laboratories Limited (ISLL) for INR 1,530 crores ... Read More

Mangalam Drugs and Organics commissions intermediate manufacturing facility

pallavi123- June 19, 2021 0

Mangalam Drugs and Organics Limited, an Indian manufacturer of active pharmaceutical ingredients (APIs), has commissioned a new intermediate manufacturing facility in Vapi, Gujarat. The API ... Read More

Novartis’ Sandoz to acquire Aspen’s Japanese pharma business

pharmanewsdaily- November 13, 2019 0

Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen ... Read More

Olon acquires API manufacturing plant in Maharashtra, India to expand global footprint

pharmanewsdaily- September 5, 2018 0

Olon, a prominent developer and manufacturer of active pharmaceutical ingredients (API) based in Italy, has strategically expanded its global operations with the acquisition of a ... Read More